Jeffrey Leiden, M.D.
Dr. Leiden is currently executive chairman of Vertex Pharmaceuticals, where he was CEO and president. During his tenure, the company dsicovered and developed four breakthrough medicines that treat the underlying cause of Cystic Fibrosis as well as the first successful human gene editing treatment for patients with Sickle Cell Disease. Earlier, he was president, COO and chief scientific officer at Abbott Laboratories. He currently serves on the boards of the Massachusetts Mutual Life Insurance Company and Casana Healthcare.
- March 2021
Added to: Tmunity Therapeutics Inc. - Philadedelphia, PA
Tmunity Therapeutics is a clinical-stage biothereapeutics company creating T-cell immunotherapy medicines for solid tumor patients. Through the University of Pennsylvania, the Parker Institute for Cancer Immunotherapy and other collaborations, the company is developing a diversified portfolio of novel treatment.